Camelus dromedarius (Arabian camel): 105084433
Help
Entry
105084433 CDS
T04642
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
cdk
Camelus dromedarius (Arabian camel)
Pathway
cdk01524
Platinum drug resistance
cdk04010
MAPK signaling pathway
cdk04115
p53 signaling pathway
cdk04148
Efferocytosis
cdk04210
Apoptosis
cdk04215
Apoptosis - multiple species
cdk04623
Cytosolic DNA-sensing pathway
cdk04650
Natural killer cell mediated cytotoxicity
cdk04657
IL-17 signaling pathway
cdk04668
TNF signaling pathway
cdk04726
Serotonergic synapse
cdk04932
Non-alcoholic fatty liver disease
cdk04933
AGE-RAGE signaling pathway in diabetic complications
cdk04936
Alcoholic liver disease
cdk05010
Alzheimer disease
cdk05012
Parkinson disease
cdk05014
Amyotrophic lateral sclerosis
cdk05016
Huntington disease
cdk05020
Prion disease
cdk05022
Pathways of neurodegeneration - multiple diseases
cdk05132
Salmonella infection
cdk05133
Pertussis
cdk05134
Legionellosis
cdk05145
Toxoplasmosis
cdk05146
Amoebiasis
cdk05152
Tuberculosis
cdk05160
Hepatitis C
cdk05161
Hepatitis B
cdk05162
Measles
cdk05163
Human cytomegalovirus infection
cdk05164
Influenza A
cdk05165
Human papillomavirus infection
cdk05167
Kaposi sarcoma-associated herpesvirus infection
cdk05168
Herpes simplex virus 1 infection
cdk05169
Epstein-Barr virus infection
cdk05170
Human immunodeficiency virus 1 infection
cdk05200
Pathways in cancer
cdk05203
Viral carcinogenesis
cdk05205
Proteoglycans in cancer
cdk05206
MicroRNAs in cancer
cdk05210
Colorectal cancer
cdk05222
Small cell lung cancer
cdk05416
Viral myocarditis
cdk05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
cdk00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
105084433 (CASP3)
04668 TNF signaling pathway
105084433 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
105084433 (CASP3)
09143 Cell growth and death
04210 Apoptosis
105084433 (CASP3)
04215 Apoptosis - multiple species
105084433 (CASP3)
04115 p53 signaling pathway
105084433 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
105084433 (CASP3)
04650 Natural killer cell mediated cytotoxicity
105084433 (CASP3)
04657 IL-17 signaling pathway
105084433 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
105084433 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
105084433 (CASP3)
05206 MicroRNAs in cancer
105084433 (CASP3)
05205 Proteoglycans in cancer
105084433 (CASP3)
05203 Viral carcinogenesis
105084433 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
105084433 (CASP3)
05222 Small cell lung cancer
105084433 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
105084433 (CASP3)
05161 Hepatitis B
105084433 (CASP3)
05160 Hepatitis C
105084433 (CASP3)
05164 Influenza A
105084433 (CASP3)
05162 Measles
105084433 (CASP3)
05168 Herpes simplex virus 1 infection
105084433 (CASP3)
05163 Human cytomegalovirus infection
105084433 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
105084433 (CASP3)
05169 Epstein-Barr virus infection
105084433 (CASP3)
05165 Human papillomavirus infection
105084433 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
105084433 (CASP3)
05133 Pertussis
105084433 (CASP3)
05134 Legionellosis
105084433 (CASP3)
05152 Tuberculosis
105084433 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
105084433 (CASP3)
05145 Toxoplasmosis
105084433 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
105084433 (CASP3)
05012 Parkinson disease
105084433 (CASP3)
05014 Amyotrophic lateral sclerosis
105084433 (CASP3)
05016 Huntington disease
105084433 (CASP3)
05020 Prion disease
105084433 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
105084433 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
105084433 (CASP3)
05416 Viral myocarditis
105084433 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
105084433 (CASP3)
04932 Non-alcoholic fatty liver disease
105084433 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
105084433 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
105084433 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
cdk01002
]
105084433 (CASP3)
Enzymes [BR:
cdk01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
105084433 (CASP3)
Peptidases and inhibitors [BR:
cdk01002
]
Cysteine peptidases
Family C14: caspase family
105084433 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
SICA_beta
Motif
Other DBs
NCBI-GeneID:
105084433
NCBI-ProteinID:
XP_010972864
LinkDB
All DBs
Position
26:18136485..18151645
Genome browser
AA seq
275 aa
AA seq
DB search
MENTENSVDSKSIKTLETNIFHGSKSMDSGLSLDNSYKMDYPEMGLCLIINIKNFHKSTG
MACRSGTDVDAANLRETFTNLKYEVRNKNDLTCEEILKLMYNVSKEDHSKRSSFICVLLS
HGEEGVIYGTDGAVDLKKLTSFFRGDSCRSLTGKPKLFIIQACRGTELDCGIETDSGVED
EMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYAHKLELMHILTRVN
RKVAIEFESFSIDSAFHAKKQIPCIVSMLTKELYF
NT seq
828 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaaaactcagtggattcaaaatccattaaaaccttggagacaaatatc
ttccatggaagcaaatcaatggactctggactatccttagacaacagttataaaatggat
tatcctgaaatgggtttatgtttaataattaatattaagaactttcataaaagtactgga
atggcatgtcggtctggtacagatgtagatgcagcaaacctcagggaaaccttcacgaac
ttgaaatacgaagtcagaaataaaaatgatcttacatgtgaagaaattttgaaattaatg
tacaatgtttctaaagaagatcatagcaaaaggagcagtttcatttgtgtgcttctaagc
catggtgaagaaggagtgatttatggaacagatggggctgttgatctgaaaaaattaaca
agcttcttcagaggggacagttgtagaagcctaaccggaaaacccaaacttttcattatt
caggcctgccgaggcacagagctggactgtgggattgagacagacagtggcgttgaggac
gaaatggcctgtcagaaaatacccgttgaggccgacttcttgtatgcatactccacggca
cctggttactattcctggagaaattcaaaggatggatcctggttcatccagtccctttgt
gcaatgctgaagcagtacgctcacaaactcgagctgatgcacattcttactcgggttaac
cgaaaggtggcaatagaattcgagtctttttccattgactctgcttttcatgcaaagaaa
cagattccatgtattgtgtccatgctcacaaaagaactatatttttaa
DBGET
integrated database retrieval system